FLT3 and acute myeloid leukemia: Another study comparing co-occurring mutations in TP53-mutated AML and TP53-WT AML demonstrated that FLT3, NPM1, and RAS gene mutations are not common in TP53-mutated AML compared with TP53-WT AML, whereas other gene mutations are not different between the two groups [57].